TETRAULT LYNN A. — SEC Form 4 filings
SEC reporting owner CIK 1645512. 21 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-03-06 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 7,000 shares, $56,974 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 11 legs across 7 filings — 88,726 shares, $5,618,780 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 37,000 shares @ $100.32 ($3,711,896) in RHYTHM PHARMACEUTICALS, INC., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | 9 | — | 8 legs · 72,000 sh · $5,402,377 | 24 |
| NEOGENOMICS INC (NEO) | Director | 8 | 1 leg · 7,000 sh · $56,974 | 3 legs · 16,726 sh · $216,402 | 12 |
| ACELYRIN, Inc. (SLRN) | Director | 2 | — | — | 3 |
| ALUMIS INC. (ALMS) | Director | 2 | — | — | 3 |
Form 4 filings — TETRAULT LYNN A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 37,000 @ $28.27 · Sale (S): 37,000 @ $100.32 · Option exercise (M): 37,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 5,307 @ $11.10 | EDGAR |
| 2026-06-11 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 5,307 @ $11.29 | EDGAR |
| 2026-06-03 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 23,077 @ $0 · Option exercise (M): 23,077 (derivative) @ $0 · Grant/award (A): 11,069 (derivative) @ $0 · Grant/award (A): 15,970 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 7,037 (derivative) @ $0 · Grant/award (A): 4,712 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 12,254 @ $0 · Option exercise (M): 12,254 (derivative) @ $0 · Grant/award (A): 16,107 (derivative) @ $0 · Grant/award (A): 23,077 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | ACELYRIN, Inc. (SLRN) | Disposition to issuer (D): 43,680 (derivative) · Disposition to issuer (D): 89,955 (derivative) | EDGAR |
| 2025-05-09 | 4 | NEOGENOMICS INC (NEO) | Purchase (P): 7,000 @ $8.14 | EDGAR |
| 2024-09-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,199 @ $18.99 · Sale (S): 3,199 @ $50.04 · Option exercise (M): 10,000 @ $4.15 · Option exercise (M): 7,501 @ $18.99 · Sale (S): 8,490 @ $49.05 · Sale (S): 8,661 @ $50.20 · +4 more | EDGAR |
| 2024-08-28 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,300 @ $18.99 · Sale (S): 4,300 @ $50.01 · Option exercise (M): 4,300 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 10,000 @ $4.15 · Sale (S): 9,593 @ $44.62 · Sale (S): 407 @ $45.37 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 11,336 @ $0 · Option exercise (M): 11,336 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,000 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 43,680 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 8,672 (derivative) @ $0 · Grant/award (A): 12,254 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 6,112 @ $15.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1645512 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →